18.38
-0.43(-2.29%)
Currency In USD
Address
1540 Broadway
New York City, NY 10036
United States of America
Phone
212 295 5800
Website
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Employees
891
First IPO Date
February 06, 2020
| Name | Title | Pay | Year Born |
| Ramy Farid | Chief Executive Officer, President & Director | 1.24M | 1965 |
| Richard A. Friesner | Co-Founder, Scientific Advisory Chairman and Director | 473,400 | 1953 |
| Jenny Herman | Chief Accounting Officer | 521,638 | N/A |
| Robert Lorne Abel | Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D | 736,839 | 1982 |
| Kenneth Patrick Lorton | Executive Vice President, Chief Technology Officer & Chief Operating Officer of Software | 736,839 | 1984 |
| Karen Akinsanya | President, Head of Therapeutics R&D and Chief Strategy Officer & Partnerships | 931,411 | 1968 |
| Richie Jain | Executive VP, CFO & Treasurer | 0 | 1984 |
| Shane Brauner | Executive VP & Chief Information Officer | 0 | 1977 |
| Jaren Irene Madden | Chief Corporate Affairs Officer & Head of Investor Relations | 0 | N/A |
| William Goddard | Co-Founder & Scientific Advisor | 0 | N/A |
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
